| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/10/2001 | US6214539 Synthetic antigen the detection of aids-related disease |
| 04/10/2001 | US6214355 DbpA compositions |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | US6214333 Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| 04/10/2001 | US6214293 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization |
| 04/10/2001 | US6214187 Analyzing nucleic acid sequences |
| 04/10/2001 | US6213557 Vehicle seat assembly with thermoformed fibrous suspension panel |
| 04/10/2001 | CA2164706C Magnetic cycle reaction |
| 04/10/2001 | CA2163151C Humanized and chimeric monoclonal antibodies that recognized epidermal growth factor receptor (egf-r). use diagnostic and therapeutic |
| 04/10/2001 | CA2130436C Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 04/10/2001 | CA2076901C Kainate-binding, human cns receptors of the eaa2 family |
| 04/10/2001 | CA2074089C Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor |
| 04/10/2001 | CA2061443C Potato plant producing essentially amylose-free starch |
| 04/10/2001 | CA2020598C Inducible expression vectors |
| 04/10/2001 | CA1341212C Osteoinductive factors |
| 04/05/2001 | WO2001023888A1 Addressable arrays using morphology dependent resonance for analyte detection |
| 04/05/2001 | WO2001023867A1 Method and device for detecting a molecular recognition reaction |
| 04/05/2001 | WO2001023822A1 Fractal absorber for heat pipes with broad range heat radiation absorptivity |
| 04/05/2001 | WO2001023619A1 Compounds displayed on replicable genetic packages and methods of using same |
| 04/05/2001 | WO2001023613A1 Human rnase h and oligonucleotide compositions thereof |
| 04/05/2001 | WO2001023607A2 Multiplex pcr for detecting ehec infections |
| 04/05/2001 | WO2001023606A2 Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria |
| 04/05/2001 | WO2001023605A2 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process |
| 04/05/2001 | WO2001023604A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 04/05/2001 | WO2001023602A1 Method for determining and modifying protein/peptide solubility |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023597A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | WO2001023596A2 Production of polyhydroxyalkanoate in plants |
| 04/05/2001 | WO2001023595A2 Reduced gravity transformation process and product |
| 04/05/2001 | WO2001023594A2 Enhanced stress tolerance in maize via manipulation of cell cycle regulatory genes |
| 04/05/2001 | WO2001023593A1 Synthetic and chimeric promoters, expression cassettes, plasmids, vectors, transgenic plants and seeds containing them, and method for producing them |
| 04/05/2001 | WO2001023592A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/05/2001 | WO2001023591A1 Process for producing transglutaminase |
| 04/05/2001 | WO2001023590A2 22196, a novel human aminopeptidase |
| 04/05/2001 | WO2001023589A2 23431, a novel human ubiquitin protease |
| 04/05/2001 | WO2001023588A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | WO2001023587A2 Serine protease |
| 04/05/2001 | WO2001023586A2 Transacylases of the paclitaxel biosynthetic pathway |
| 04/05/2001 | WO2001023585A1 23484, a human ubiquitin protease |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023583A2 Thermostable enzyme promoting the fidelity of thermostable dna polymerases- for improvement of nucleic acid synthesis and amplification in vitro |
| 04/05/2001 | WO2001023582A1 Whole cell catalyst comprising a hydantoinase, a racemase and a carbamoylase |
| 04/05/2001 | WO2001023581A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 04/05/2001 | WO2001023580A2 Polyhydroxyalkanoate synthase genes |
| 04/05/2001 | WO2001023579A1 Human kinase proteins and polynucleotides encoding the same |
| 04/05/2001 | WO2001023578A1 The gene cluster involved in aclacinomycin biosynthesis, and its use for genetic engineering |
| 04/05/2001 | WO2001023577A2 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences |
| 04/05/2001 | WO2001023576A1 Protein production using ashbya gossypii |
| 04/05/2001 | WO2001023575A2 Wuschel (wus) gene homologs |
| 04/05/2001 | WO2001023574A1 Molecular markers of the pre-germination stage of plant seeds and use thereof in elisa tests |
| 04/05/2001 | WO2001023573A1 Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023571A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | WO2001023570A2 Methods and compositions relating to sodium channel beta-1a subunits |
| 04/05/2001 | WO2001023569A1 Cytokine receptor materials and methods |
| 04/05/2001 | WO2001023568A2 Members of the iap gene family |
| 04/05/2001 | WO2001023567A1 Membrane-bound protein-60 |
| 04/05/2001 | WO2001023566A1 Novel human organic anion transporter-like proteins and polynucleotides encoding the same |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023564A1 Secreted factors |
| 04/05/2001 | WO2001023563A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | WO2001023562A2 Osteoprotegerin regulatory region |
| 04/05/2001 | WO2001023561A2 Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats |
| 04/05/2001 | WO2001023560A2 Isolated peptides which bind to mhc class ii molecules, and uses thereof |
| 04/05/2001 | WO2001023559A1 Osteoclast differentiation factor regulatory region |
| 04/05/2001 | WO2001023558A2 Human secretory molecules |
| 04/05/2001 | WO2001023557A1 Novel polypeptides and genes encoding the same |
| 04/05/2001 | WO2001023556A1 Novel hemopoietin receptor protein, nr12 |
| 04/05/2001 | WO2001023555A1 Method of prolonging normal cell life span |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023553A2 Metastasis-associated antigen c4.4a |
| 04/05/2001 | WO2001023552A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | WO2001023551A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 04/05/2001 | WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 04/05/2001 | WO2001023549A1 Rat osteoclast differentiation factor |
| 04/05/2001 | WO2001023548A1 Dna-cleaving rnase p rna |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023545A1 Dna containing variant frt sequences |
| 04/05/2001 | WO2001023544A1 Nucleic acid fragment, recombinant vector containing the same and method of promoting the expression of structural gene by using the same |
| 04/05/2001 | WO2001023543A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | WO2001023542A1 Transformant producing secondary metabolite modified with functional group and novel biosynthesis genes |
| 04/05/2001 | WO2001023541A2 Compositions and methods for altering gene expression |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023539A2 Genes encoding sterol delta-15 reductase in plants |
| 04/05/2001 | WO2001023537A1 Process for enhancing electric field-mediated delivery of biological materials into cells |
| 04/05/2001 | WO2001023533A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 04/05/2001 | WO2001023530A1 Genes expressed in germinating seeds and their uses |
| 04/05/2001 | WO2001023525A2 Methods of producing cloned and transgenic mammals |
| 04/05/2001 | WO2001023459A1 Particle structures with receptors for analyte detection |
| 04/05/2001 | WO2001023432A1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 04/05/2001 | WO2001023431A1 Derivatives of antibody against ganglioside gm2 |
| 04/05/2001 | WO2001023427A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/05/2001 | WO2001023425A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | WO2001023424A1 A phosphatidylethanolamine binding protein (pebp-2) and uses thereof |
| 04/05/2001 | WO2001023422A1 Vaccine |
| 04/05/2001 | WO2001023421A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | WO2001023416A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | WO2001023414A2 Immunologically significant herpes simplex virus antigens |